메뉴 건너뛰기




Volumn 5, Issue 3, 2004, Pages 182-183

Tramadol - Biovail Corporation
[No Author Info available]

Author keywords

[No Author keywords available]

Indexed keywords

MIRTAZAPINE; PARACETAMOL; RALIVIA; TRAMADOL; VENLAFAXINE;

EID: 2942687030     PISSN: 11745886     EISSN: None     Source Type: Journal    
DOI: 10.2165/00126839-200405030-00010     Document Type: Article
Times cited : (10)

References (5)
  • 1
    • 2942657847 scopus 로고    scopus 로고
    • Biovail NDA For Ralivia ER - Tramadol Extended Release Tablets - Accepted for Review
    • Biovail Corporation. Media Release: 26 Feb Available from URL:
    • Biovail Corporation. Biovail NDA For Ralivia ER - Tramadol Extended Release Tablets - Accepted for Review. Media Release: 26 Feb 2004. Available from URL: http://www.biovail.com
    • (2004)
  • 2
    • 2942642695 scopus 로고    scopus 로고
    • Biovail Submits NDA for Ralivia FlashDose
    • Biovail Corporation. Media Release: 11 Mar Available from URL:
    • Biovail Corporation. Biovail Submits NDA for Ralivia FlashDose. Media Release: 11 Mar 2004. Available from URL: http://www.biovail.com
    • (2004)
  • 3
    • 1242271414 scopus 로고    scopus 로고
    • Serotonin syndrome resulting from coadministration of tramadol, venlatfxine, and mirtazapine
    • Mar
    • Houlihan DJ. Serotonin syndrome resulting from coadministration of tramadol, venlatfxine, and mirtazapine. Annals of Pharmacotherapy 38: 411-3, No. 3, Mar 2004
    • (2004) Annals of Pharmacotherapy , vol.38 , Issue.3 , pp. 411-413
    • Houlihan, D.J.1
  • 4
    • 2942662286 scopus 로고    scopus 로고
    • Biovail Presents Tramadol Results at American College of Rheumatology
    • Biovail Corporation. Media Release: 28 Oct Available from URL:
    • Biovail Corporation. Biovail Presents Tramadol Results at American College of Rheumatology. Media Release: 28 Oct 2002. Available from URL: http://www.biovail.com
    • (2002)
  • 5
    • 2942679697 scopus 로고    scopus 로고
    • Biovail reports second positive phase III clinical result for tramadol extended release formulation
    • Biovail Corporation. Media Release 14 Jan Available from URL: (3 pages]
    • Biovail Corporation. Biovail reports second positive phase III clinical result for tramadol extended release formulation. Media Release (3 pages], 14 Jan 2002. Available from URL: http://www.biovail.com
    • (2002)


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.